Category: CannabisNewsWire Release

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Earnings Conference Call, Webcast

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, has scheduled a conference call and webcast to discuss its earnings for the first half of 2022. The call is slated for Monday, Aug. 15, 2022, at 4:30 p.m. ET. the company plans to release its financial report and numbers prior to the call. During the call, company officials will discuss the financial and operations results as well as provide an update on the company’s operations, house of brands and life sciences strategies; the event will also include time for a Q&A. An archived replay of the call will be available on the company website following the call.

To view the full webcast, visit https://cnw.fm/J0WlF

To view the full press release, visit https://cnw.fm/I8T95

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands designed to deliver the most compelling customer experiences in the world, one community at a time. As the operator of one of the extensive outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to commercial, house of brands and life sciences divisions. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

American Cannabis Partners Has Vested Interest in Cannabis Act Just Passed by U.S. House

  • MORE Act passed by House, now moves to Senate for consideration
  • Bill would “reverse decades of injustices waged on Americans, and especially those from communities of color,” says House Judiciary chair
  • American Cannabis Partners operates in two states, Michigan and California, where cannabis has been legalized

The government is making moves once again to remove cannabis from the list of banned controlled substances, with the U.S. House of Representatives passage of the Marijuana Opportunity Reinvestment and Expungement (“MORE”) Act (https://cnw.fm/9gXLk). The bill now moves to the Senate, and cannabis companies such as American Cannabis Partners (“ACP”) will be watching closely to see what happens next.

The U.S. House of Representatives has passed the MORE Act before, a “Forbes” article reported, a bill that would end the federal prohibition on cannabis by removing it from the list of banned controlled substances. The article noted that the MORE Act was introduced by House Judiciary Chairman Jerrold Nadler, a Democrat from New York, and passed the House with 220 “yea” votes to 204 “nay” votes.

“Cannabis is legal for adult use in 19 states and for medical use in 36 states,” the article reports. “This bill would end the federal ban but leave legalization up to the states. The legal industry generated $25 billion in sales last year, a 43% increase over 2020, and is expected to hit $65 billion in 2030.

“During his opening statement, Nadler said that the bill, if made into law, would reverse decades of injustices waged on Americans, and especially those from communities of color,” the article continued. “‘Whatever one’s views are on the use of marijuana for recreational or medicinal use, the policy of arrest, prosecution and incarceration at the federal level has proven both unwise and unjust,’ Nadler said. ‘For far too long, we have treated marijuana as a criminal justice problem, instead of as a matter of personal choice and public health.’”

During debate on the bill, Troy Carter, a Democrat from Louisiana, stated that 91% of Americans want some form of cannabis to be legal and that there are more important priorities cops should be focused on. Carter noted that “law enforcement cannot afford to chase small pot offenders when violent crime is on the rise nationwide. . . . The war on marijuana is a costly relic of the past.”

American Cannabis Partners, along with other companies operating in the cannabis space, clearly has a vested interest in the outcome of this legislation. ACP operates in two states, Michigan and California, where cannabis has been legalized. In addition, the company is in the process of exploring land acquisition and project development strategies for expanding operations to additional states.

ACP is focused on three business segments: real estate, acquisition and development of proprietary assets, and ongoing cultivation operations. Led by a seasoned management team with more than three decades of canna-business experience, ACP is guided by its strategy to capture opportunities in real estate and licensing in states that have recently passed cannabis legalization legislation, thereby equipping the company to capitalize on possible future federal interstate commerce opportunities.

For more information, visit the company’s website at www.ACPFarms.com.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Studies Question Usefulness of THC Testing to Establish Impairment

For decades, law enforcement has used standardized equipment called breathalyzers to determine the blood-alcohol content of drivers and police-impaired driving. These tests take mere seconds to administer and can give police a decent estimation of how impaired a driver is. As cannabis reform has swept across the country and more states have legalized recreational cannabis, law enforcement and cannabis legalization opponents have argued that legalizing cannabis will inevitably lead to higher levels of impaired driving and road incidents.

We still don’t have a standard test to quickly measure delta-9 THC blood levels. Furthermore, there is relatively little evidence that the level of THC in the breath or blood from recent marijuana use is even associated with impaired driving. With at least a dozen states now allowing recreational cannabis use among adults aged 21 and older, the need to understand the correlation between recent cannabis use and impaired driving as well as develop ways to effectively measure impairment has become even more urgent.

A recent study published in “Scientific Reports” did just that, peering into the cannabis plant to study how cannabinoids impact impairment. Two researchers from California ran a one-year clinical study with 74 users who reported using cannabis daily for approximately nine years. The participants had an average age of 25 years, and most of them reported that smoking or vaping were their most preferred methods of consuming cannabis.

One group of study participants had a baseline THC blood level that surpassed THC limits in five U.S. states, even when they were completely sober. This means that in these five states, the study participants were not legally allowed to get behind a wheel even if they had not used any cannabis. Previous studies from Michael DeGregorio, one of the researchers behind the recent study, and other researchers had found that marijuana use could result in short-term functional impairment.

The extent of this impairment depends on factors such as frequency of use and age. Building on previous research, this study found that 16 cannabis users had more than 5ng/ml of delta-9 THC in their blood even though they had abstained from cannabis and were not impaired. Breath and blood samples indicated high THC levels despite no recent cannabis use and no impairment.

Participants who had used cannabis for longer periods had higher baseline THC concentration levels, which in many cases exceeded state limits. However, their duration of impairment was decreased, meaning they were impaired for shorter periods of time even though their baseline THC levels remained elevated. The researchers concluded that THC levels in exhaled breath and blood were not reliable indicators of THC impairment.

As more science-backed data becomes available, policymakers are likely to evolve and enact measures that allow companies such as Advanced Container Technologies Inc. (OTC: ACTX) to serve indoor cannabis growers without any fear that reprisals will follow such commercial activity.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Health Canada Panel Gives CBD the Nod for Mainstream Retail

Cannabis extract cannabidiol (CBD) has become extremely popular over the past decade due to claims of its medical efficacy. CBD is said to be effective against a wide variety of medical issues, and it has even been approved as a major ingredient in a drug used to treat seizures in pediatric epilepsy.

Additionally, the cannabinoid is so versatile in its applications that it can be infused in a range of foods and beverages and still be effective. However, there have been questions about whether approving CBD for mainstream retail would have adverse medical outcomes, especially considering the fact that it is an active ingredient in an approved drug.

CBD retailers and users in Canada will now be happy to know that the country’s top regulator has deemed CBD use by healthy adults without a prescription as “safe and tolerable.” A nine-member Health Canada panel, the Science Advisory Committee on Health Products Containing Cannabis, ruled that short-term CBD use (30 days maximum) at a dose of 20 to 200 mg. per day is safe and tolerable.

This decision comes three years after Canada’s top health regulator formed a team of experts to review whether or not CBD-infused products should be approved for mainstream retail sale without the need for a doctor’s prescription or in a recreational cannabis store.

Health Canada may not have any legal obligation to act on the panel’s recommendation, but it could prove to be a boon for Canada’s nonexistent legal CBD market. As it stands, the country considers CBD a controlled substance and regulates it like delta-9 THC, the main psychoactive component in cannabis. The result is that most of the CBD sellers in Canada operate in the illicit market. This has led to an influx of untested and unregulated CBD products that could be putting consumers at risk.

According to Paul Pedersen, CEO of Nextleaf, Vancouver-based cannabis extraction company, Canada’s black market for CBD products is pulling in an estimated $4 billion per year. If Health Canada decides to act on the panel’s recommendation and approves mainstream retail sales of CBD, Pedersen envisions CBD products will be sold next to other dietary supplements in drug and grocery stores. Speaking to MJBizDaily, he said that he is looking forward to moving CBD sales to any location that sells vitamins.

As per the panel, there are plenty of Canadians who would like to access cannabis-infused products without the need for a physician’s oversight. Still, the panel encouraged CBD manufacturers to put warning labels on their products.

The panel also noted that, unlike THC, cannabidiol was not psychoactive and won’t get most adults high. Furthermore, the panel did not distinguish between hemp or marijuana-derived CBD and did not conclude that CBD was therapeutically effective.

Given that Canada has blazed a trail that other developed countries have followed, it isn’t far-fetched to expect that the recommendations made on selling CBD in mainstream retail outlets will be taken up so that companies such as American Cannabis Partners can have the leeway to market these products as dietary supplements or any other form they choose.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Advanced Container Technologies Inc. (ACTX) GrowPods May be Part of Solution to Global Food Security

  • In 2021, a staggering 45 million people were at emergency levels of acute hunger
  • Providing access to food, sustainable food systems are key to WFP’s vision of eradicating food insecurity and malnutrition
  • GrowPods create an optimum controlled environment for growing a wide range of crops in a variety of environments and climates

With hunger on the rise again, companies and communities are working together to find realistic solutions. The world’s largest humanitarian organization, the World Food Programme (“WFP”), has identified access to food and sustainable food systems as two of eight key targets in its vision to eradicate food insecurity and malnutrition (https://cnw.fm/ZcoK6). Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of GrowPods, environmentally controlled micro-farms that allow cultivation of ultra-clean crops all year long, believes its products may be part of that solution.

“The world today is more complex and volatile than it was five years ago,” declares WFP in its 2022–2025 strategic plan. “Hunger has been on the rise since 2014. The situation deteriorated drastically in 2020, with up to 811 million people classified as chronically hungry. Across the countries where WFP operates, an estimated 283 million people needed urgent food assistance in 2021. A staggering 45 million were at emergency levels of acute hunger and more than half a million faced famine-like conditions.”

The organization’s “vision for 2030” calls for the world to eradicate food insecurity and malnutrition and for national and global actors to partner together to achieve several goals including providing access to food and sustainable food systems (https://cnw.fm/fgZWf). According to WFP, turning the tide against hunger includes, in part, “sustainable consumption and production to reduce food loss and waste.

ACTX’s GrowPods appear ideally aligned to these essential initiatives. Modular, stackable and mobile vertical growing environments, these game-changing micro-farms are designed to maximize yield and automation. Made from fully insulated, food-grade shipping containers, GrowPods have been modified to create an optimum controlled environment for growing a wide range of horticultural and agricultural products in a variety of environments and climates.

“In a world of plenty, where enough food is produced to feed everyone on the planet, hunger should be a thing of the past,” WFP declares. “However, conflict, climate change, disasters, inequality and — most recently — the COVID-19 pandemic mean one in nine people globally is still going to bed hungry and famine looms for millions.”

ACTX is pleased to join the efforts to make food sustainability both a priority and a reality by offering a way to produce multiple high-yield harvests every year with no pesticides and using fewer resources (https://cnw.fm/OnS39).

For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Generation of CBD Products Under “Ko” Branding by Japanese Licensee Premier Wellness Science Co., Ltd.

  • Lexaria’s patented DehydraTECH(TM) has 26 granted patents worldwide, including four in Japan
  • Lexaria stands to gain substantial revenue through the licensing of DehydraTECH technology across minimum quarterly payments for license use by Premier and royalties for products sold
  • By 2028, the CBD market is expected to reach US$47.22 billion, driven by increased demand for CBD use in health and wellness

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms and developer of the patented DehydraTECH(TM) technology for the delivery of fat-soluble molecules and drugs, has announced that Japanese Licensee, Premier Wellness Science Co., Ltd., has officially launched the first generation of its new cannabidiol (“CBD”) products under the brand, “Ko,” on July 21, 2022, for the Japanese consumer market (https://cnw.fm/Pm6hK). The exclusive rights between Premier and Lexaria are subject to two previously issued licenses for using DehydraTECH technology in Japan for non-pharmaceutical cannabinoid products. As of July 28, 2022, Lexaria has been granted 26 patents worldwide.

Under the terms of the license agreement with Lexaria, Premier purchased rights to the company’s DehydraTECH technology for use in the non-pharmaceutical market for CBD and hemp ingredients in oral liquid and non-liquid product forms, including topical, hair-care, lip-care, and cosmetics. To retain ongoing exclusivity, the minimum quarterly payments from Premier to Lexaria will begin September 1, 2022, and will total US$4,527,500 during the first five years of the agreement. Additional payment beyond five years will be required to keep the license in good standing.

The “Ko” brand is focused on the endocannabinoid system and circadian rhythm, supporting the health and wellness of all consumers, specifically highlighting the concept of wellness for all, and will contain CBD and other botanical extracts. Ko-branded products containing DehydraTECH delivery technology are expected to be introduced during Q2 2023, following a rigorous product development process and formula optimization. 

Premier will create its own e-commerce infrastructure with digital marketing campaigns in collaboration with the licensee’s parent company, Premier Anti-Aging Co, Ltd., listed on the Tokyo Stock Exchange under the ticker symbol ‘4934:JP.’ Wholesale of the “Ko” brand will be done with a third-party Japanese-based distributor, also listed on the Tokyo Stock Exchange, to expand sales reach. The distributor and logistics supplier has shipped more than 3.5 billion products during the fiscal year and comprises more than 50,000 products and over 50,000 retail locations across the cosmetics, OTC pharmaceuticals, and nutraceutical wholesale industries.

In addition to the licensee payments, Lexaria will receive royalties from DehydraTECH-enabled product sales, which are anticipated to be greater than the negotiated minimum payments for the license use if Premier reaches revenue targets. Even with the worst-case projected revenue, Lexaria could expect royalties of US$5 million annually by the fifth year of the contract.

Lexaria’s DehydraTECH technology speeds up delivery, increases bioavailability, increases brain absorption, improves drug potency, reduces drug administration costs, and masks unwanted tastes. Animal studies have demonstrated the propensity of the technology to elevate the quantity of the drug delivered across the blood-brain barrier by as much as 1,900 percent. The technology is suitable for use within a wide range of product formats, including pharmaceuticals, nutraceuticals, consumer packaged goods, and over-the-counter capsules, pills, tablets, and oral suspension. 

The CBD market is primarily driven by increased demand for use in health and wellness and was valued at US$4.9 billion in 2021. The market is expected to grow at a CAGR of 21.3%, resulting in a value of US$47.22 billion by 2028 (https://cnw.fm/8yp9F). Lexaria’s DehydraTECH technology is anticipated to leverage this growing market, using its patents and exclusive licensing to support the demand created within the industry.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Federal Health Agencies Consider Funding Research into Minor Cannabinoids

If you ask the average American if they know what cannabinoids are, they’ll probably mention delta-9 THC, the main psychoactive component in cannabis, or cannabidiol (CBD). These are the most abundant cannabinoids in the cannabis plant as well as the most popular. As a result, they have received a lot of public and scientific attention in the past couple of years amid sweeping cannabis reform.

What many people don’t know is that the cannabis plant produces more than 100 cannabinoids, although most of them occur in small quantities. Cannabis also produces a variety of terpenes and flavonoids that significantly impact the quality of the final product. A group of federal health agencies is now looking into funding research on the possible therapeutic benefits of minor cannabinoids and cannabis terpenes.

The announcement was made via a notice of special interest (NOSI) posted by the National Institutes of Health (NIH) and eight of its component agencies; the NOSI was titled  “Promoting Mechanistic Research on Therapeutic and Other Biological Properties of Minor Cannabinoids and Terpenes.”

Every cannabinoid except THC is considered a minor cannabinoid. While THC has been subject to plenty of research, especially in recent years, there is little scientific research on lesser-known or minor cannabinoids, including CBN, CBG and delta-8 THC. The notice states that the agencies are interested in studies involving model organisms and human subjects that look into the impact of terpenes and minor cannabinoids.

The notice goes on to say there is specific interest in preclinical studies of minor cannabinoid-terpene combinations and combinations of minor cannabinoids and other natural products that could enhance health benefits and tamp down on side effects. The notice stated that terpenes and minor cannabinoids may be able to alleviate a wide variety of pathological diseases and conditions; it also encouraged experts from multiple fields to collaborate in this much-needed research.

As per the notice, the eight agencies under the NIH will be tasked with different research objectives and will have specific research requests for scientists. Those agencies include the National Cancer Institute (NCI), the National Center for Complementary and Integrative Health (NCCIH), the National Institute on Aging (NIA), the National Eye Institute (NEI), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA), the National Institute of Dental and Craniofacial Research (NIDCR) and  the National Institute of Neurological Disorders and Stroke (NINDS).

NCCIH is interested in the impact of minor cannabinoids and terpenes on pain, NCI is looking to understand how minor cannabinoids and terpenes can affect cancer treatment, and NIAAA plans on researching how CBD and other cannabinoids can impact alcohol use disorder treatment.

This interest in studying the effects of minor cannabis compounds could signal that federal health agencies are beginning to recognize that marijuana does have therapeutic potential, and the time may not be far off when cannabis policy will be overhauled at the federal level so that legitimate companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) can operate nationally if they so choose.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Governors’ Group Recommends Addressing Impaired Driving by Collaborating with Budtenders

As more states have passed cannabis legislation, cannabis reform opponents and even law enforcement have raised the question of how to police cannabis-impaired driving. This is a valid concern, especially when you consider the fact that there is no standardized test for cannabis blood levels.

If the government would like to successfully discourage people from driving while under the influence of cannabis, a report from a governor’s group recently posited, it would have to ditch cannabis stereotypes and work with budtenders. The new report, which was issued by a group with the backing of all 50 governors’ offices, emphasizes that public education campaigns on the harms of impaired driving should not stereotype or mock cannabis consumers. Rather, the report said, this messaging would be more effective if it comes from sources that are at the heart of the cannabis industry and have the trust of consumers.

We still don’t know a lot about cannabis-impaired driving and its impact on accident statistics. A June report from the Governors Highway Safety Association revealed that cannabis reform has had mixed results on road accidents and fatalities. The report showed that some studies have found a reduction in accidents after medical cannabis legalization while others have found an increase in traffic incidents post-legalization.

The report was funded by the National Alliance to Stop Impaired Driving and Responsibility.org. The Governors Highway Safety Association acknowledged that law enforcement’s ability to determine causation is limited by a lack of standardized tools to measure active THC impairment.  Even so, the report noted that the public is increasingly seeing cannabis-impaired driving as less risky, which has necessitated updated public education initiatives.

The aforementioned report provided a couple of recommendations to guide states with legal cannabis markets on how they can effectively address THC-impaired driving. One such recommendation was to use messengers who are essentially community-based industry insiders and who regularly interact with cannabis consumers rather than government representatives.

The recommendations provide an exception to law enforcement officials who have been trained to detect drug impairment. Furthermore, the report suggested that cannabis safety messages from law enforcement should ideally come from “less conventional law enforcement representatives,” such as native speakers, women officers and officers who are people of color.

The Governors Highway Safety Association also recommended working with budtenders or retail marijuana salespeople to push cannabis safety messaging to consumers because they will have a better chance of delivering these messages effectively. The organization emphasized that using nontraditional and diverse messengers, especially those trusted by the community, would improve cannabis-safety message reception.

Teaming up with cannabis industry actors, such as Prime Harvest Inc., could be a great step because consumers already trust these entities enough to buy their products, so any safety messages delivered by the personnel at these companies may elicit a better reception and stand a higher chance of being implemented to minimize impaired driving.

NOTE TO INVESTORS: The latest news and updates relating to Prime Harvest Inc. are available in the company’s newsroom at https://cnw.fm/PRIME

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Poised in the ‘Future of Agriculture’

Advanced Container Technologies (OTC: ACTX) today announced that it is operating in a sector that Barclays Bank says is gaining traction as a sector for investment. According to Jed Lynch, head of Americas, sustainable and impact investment banking at Barclays, “Agriculture has historically been viewed as a mature industry, but we are now seeing significant technology-led innovation across the sector. As a result, we’re seeing a noticeable increase in high-growth startups, venture funding, M&A activity and public-market interest in this space.”

“We are in the right sector at the right time,” Douglas Heldoorn, CEO of Advanced Container Technologies, said in the news release. “Controlled environment farming (‘CEF’) with systems like GrowPods represent nothing less than the future of agriculture.”

To view the full press release, visit https://cnw.fm/AzLlZ

About Advanced Container Technologies Inc.

Advanced Container Technologies is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Tennessee’s First Marijuana Restaurant Slated to Open This Month

The state of Tennessee will soon join the growing number of states that have launched markets for cannabis-infused products: Buds & Brews, the first cannabis business in Tennessee, is slated to open its doors to the public this month in Georgetown. The marijuana business first announced that it would be opening earlier this year, stating that it will provide traditional bar foods alongside cannabis-infused condiments that are manufactured and presealed in a facility before being sent to the restaurant.

Buds & Brews president and owner Michael Solomon says patrons will be able to order regular food and season it with THC and CBD-infused condiments. He said that the company has infused cannabis into the 25 most common condiments ranging from steak sauce and ketchup to ranch dressing and honey mustard. Using dosing spoons that are in line with the state’s legal cannabis limits, patrons will be able to receive one to five milligrams of cannabis-infused condiment per serving.

Solomon says these doses are so small that you could safely try a variety of condiments in one sitting. This controlled microdosing is especially beneficial for rookies who would like to give cannabis products a chance. On top of the condiments, Buds & Brews will also offer THC-infused desserts and mocktails on its menu. Solomon noted that the business will include novelty products such as deep-fried cannabis leaves on its menu.

Solomon has spent the past decade or so learning how to grow top-of-the-line cannabis, and he is now using his knowledge to enter the restaurant industry to bring top-shelf cannabis products to the public. He is also the founder and owner of Craft Cannabis, a marijuana company that develops THC-infused products, including the marijuana-infused condiments that will be available at Buds & Brews.

As per state law, Craft Cannabis only uses THC derived from industrial hemp with less than 0.35% THC. Craft Cannabis also handles the entirety of its operations locally, with Solomon saying that the firm cultivates, extracts and develops different cannabis-infused retail products in Tennessee.

Buds & Brews cofounder Dalton Crow has deep roots in the bar industry; his family owns 10 establishments in middle Tennessee, and he grew up steeped in the sector. While Crow’s family’s has been involved in the bar scene, Crow has not; Buds & Brews will be his first personal venture. In a news interview, Crow said that he was excited to team up with “some great guys” and make his own footprint in the bar and restaurant segment.

As more states and jurisdictions loosen their marijuana restrictions, industry players such as Flora Growth Corp. (NASDAQ: FLGC) are likely to come up with more innovative products targeting different segments of the market.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.